Edition:
United States

AcelRx Pharmaceuticals Inc (ACRX.OQ)

ACRX.OQ on NASDAQ Stock Exchange Global Market

2.90USD
18 Jul 2018
Change (% chg)

-- (--)
Prev Close
$2.90
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
76,420
52-wk High
$5.75
52-wk Low
$1.58

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.19 December 19 Jul 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 3 3 2 2
(3) HOLD 3 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.50 2.40 2.50 2.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 5 2.43 8.70 0.00 18.58
Quarter Ending Dec-18 5 1.31 4.40 0.00 14.05
Year Ending Dec-18 6 5.50 11.50 0.00 30.85
Year Ending Dec-19 6 20.14 30.20 9.10 70.04
Earnings (per share)
Quarter Ending Sep-18 6 -0.19 -0.10 -0.24 -0.05
Quarter Ending Dec-18 6 -0.22 -0.12 -0.32 -0.13
Year Ending Dec-18 6 -0.83 -0.55 -0.99 -0.86
Year Ending Dec-19 6 -0.74 -0.45 -1.00 -0.24

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 1.15 0.34 0.81 70.17
Quarter Ending Dec-17 5.25 0.74 4.51 85.90
Quarter Ending Sep-17 2.22 1.49 0.73 32.88
Quarter Ending Jun-17 2.27 2.66 0.39 17.28
Quarter Ending Mar-17 1.80 3.11 1.30 72.32
Earnings (per share)
Quarter Ending Mar-18 -0.24 -0.23 0.01 -3.16
Quarter Ending Dec-17 -0.20 -0.20 0.00 -1.68
Quarter Ending Sep-17 -0.27 -0.28 0.01 -4.36
Quarter Ending Jun-17 -0.28 -0.29 0.01 -2.95
Quarter Ending Mar-17 -0.27 -0.34 0.07 -26.72

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 2.43 3.04 2.84 3.65 18.58
Quarter Ending Dec-18 1.31 1.64 1.64 2.05 14.05
Year Ending Dec-18 5.50 6.60 6.44 7.75 30.85
Year Ending Dec-19 20.14 21.97 21.81 21.36 70.04
Earnings (per share)
Quarter Ending Sep-18 -0.19 -0.21 -0.21 -0.21 -0.05
Quarter Ending Dec-18 -0.22 -0.25 -0.25 -0.26 -0.13
Year Ending Dec-18 -0.83 -0.89 -0.89 -0.92 -0.86
Year Ending Dec-19 -0.74 -0.79 -0.79 -0.88 -0.24

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 1 0
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 0 0 1 0
Year Ending Dec-19 0 0 1 0
Earnings
Quarter Ending Sep-18 0 0 1 0
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 0 0 1 0
Year Ending Dec-19 0 0 1 0